Department of Pharmacy Practice
Overview
The Department Pharmacy Practice, at NIPER, HAJIPUR was established in the year 2007. The aim of the Department is to impart patient oriented pharmacy education and train the students in Pharmacy Practice on par with international standards; the primary goal of the department is to train the students preparing for careers in Pharmacy Practice including teaching and research in an academic or industrial setting or in pharmaceutical companies and government research organizations.
Courses offered
The department offers postgraduate M.Pharm. (Pharmacy Practice) and Doctoral (Pharmacy Practice) and post-Doctoral courses programmes. The Pharmacy Practice programme is run in collaboration with Mahavir Cancer Institute & Research Centre & Rajendra Memorial Research Institute of Medical Sciences (RMRIMS) in patna and promote quality education and research with Master’s, Doctoral courses.
Objectives:
This course is designed to impart the basic knowledge and skills that are required to practice pharmacy including the provision of pharmaceutical care services to both healthcare professionals and patients in clinical settings. This course aims to enable the students to understand the different treatment approaches in managing various disease conditions and optimizing drug therapy of a patient by individualizing the treatment plan through evidence-based medicines. Provide the students an opportunity to learn drug development process especially the phases of clinical trials and also the ethical issues involved in the conduct of clinical research, designing, conducting and managing clinical trials. The department intends to promote research and service, demonstrating excellence in professional practice and outreach. The department of pharmacy practice is committed to review the patient record and each prescription presented for supply for the purpose of promoting therapeutic appropriateness by indentifying : (i) Over utilization or under utilization (ii) Therapeutic duplication (iii) Drug-disease interactions (iv) Drug-drug interactions (v) Incorrect drug dosage or duration of drug treatment (vi) Drug-allergy interactions (vii) Correlation of availability of drugs (to avoid artificial shortage of drugs) (viii) Clinical abuse/misuse (ix) Promotion of rational drug use (x) Patient counseling.
Research Activities
Focused disease areas: HIV, Tuberculosis, Leishmaniasis, Cancer & Cardiovascular disorders
- Medication Safety: ADR/AE monitoring and reporting, pharmacovigilance and materiovigilance activities, signal detection, and risk assessment.
- Patient Reported Outcome Measures: Developing and validating PROMs, using PROMs in routine clinical practice to monitor patient outcomes and other health-related parameters
- Drug Utilization Evaluation: Assessing drug use patterns, evaluating drug effectiveness and safety, and identifying areas for improvement in drug therapy.
- Affordability and Accessibility: Assessing drug prices and affordability, evaluating access to essential medicines, and identifying strategies to improve access and affordability.
- Clinical Biomarker Studies: Conducting clinical biomarker studies on infectious diseases, antimicrobial resistance, and biomarker validation for disease diagnosis and treatment monitoring.
Faculty
